387 related articles for article (PubMed ID: 31986080)
1. Omics and Cardiometabolic Disease Risk Prediction.
Tahir UA; Gerszten RE
Annu Rev Med; 2020 Jan; 71():163-175. PubMed ID: 31986080
[TBL] [Abstract][Full Text] [Related]
2. Biomarkers for the prediction of type 2 diabetes and cardiovascular disease.
Herder C; Karakas M; Koenig W
Clin Pharmacol Ther; 2011 Jul; 90(1):52-66. PubMed ID: 21654741
[TBL] [Abstract][Full Text] [Related]
3. Linking of metabolomic biomarkers with cardiometabolic health in Chinese population.
Sun L; Li H; Lin X
J Diabetes; 2019 Apr; 11(4):280-291. PubMed ID: 30239137
[TBL] [Abstract][Full Text] [Related]
4. Omics technologies in personalized combination therapy for cardiovascular diseases: challenges and opportunities.
Banerjee S; Prabhu Basrur N; Rai PS
Per Med; 2021 Sep; 18(6):595-611. PubMed ID: 34689602
[TBL] [Abstract][Full Text] [Related]
5. Integrated metabolomics and genomics: systems approaches to biomarkers and mechanisms of cardiovascular disease.
Shah SH; Newgard CB
Circ Cardiovasc Genet; 2015 Apr; 8(2):410-9. PubMed ID: 25901039
[TBL] [Abstract][Full Text] [Related]
6. On the Road to Accurate Biomarkers for Cardiometabolic Diseases by Integrating Precision and Gender Medicine Approaches.
Scola L; Giarratana RM; Torre S; Argano V; Lio D; Balistreri CR
Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31795333
[TBL] [Abstract][Full Text] [Related]
7. A Decade of Genetic and Metabolomic Contributions to Type 2 Diabetes Risk Prediction.
Merino J; Udler MS; Leong A; Meigs JB
Curr Diab Rep; 2017 Nov; 17(12):135. PubMed ID: 29103096
[TBL] [Abstract][Full Text] [Related]
8. The Need for Multi-Omics Biomarker Signatures in Precision Medicine.
Olivier M; Asmis R; Hawkins GA; Howard TD; Cox LA
Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31561483
[TBL] [Abstract][Full Text] [Related]
9. "Omics" in pharmaceutical research: overview, applications, challenges, and future perspectives.
Yan SK; Liu RH; Jin HZ; Liu XR; Ye J; Shan L; Zhang WD
Chin J Nat Med; 2015 Jan; 13(1):3-21. PubMed ID: 25660284
[TBL] [Abstract][Full Text] [Related]
10. Multi-omic prediction of incident type 2 diabetes.
Carrasco-Zanini J; Pietzner M; Wheeler E; Kerrison ND; Langenberg C; Wareham NJ
Diabetologia; 2024 Jan; 67(1):102-112. PubMed ID: 37889320
[TBL] [Abstract][Full Text] [Related]
11. [A multi-omics approach to investigate the etiology of non-communicable diseases: recent advance and applications].
Pang YJ; Lyu J; Yu CQ; Sun DJY; Li LM
Zhonghua Liu Xing Bing Xue Za Zhi; 2021 Jan; 42(1):1-9. PubMed ID: 33503692
[TBL] [Abstract][Full Text] [Related]
12. Biological determinants of health: Genes, microbes, and metabolism exemplars of nursing science.
Ferranti EP; Grossmann R; Starkweather A; Heitkemper M
Nurs Outlook; 2017; 65(5):506-514. PubMed ID: 28576296
[TBL] [Abstract][Full Text] [Related]
13. Integrating omics to unravel the stress-response mechanisms in probiotic bacteria: Approaches, challenges, and prospects.
Gandhi A; Shah NP
Crit Rev Food Sci Nutr; 2017 Nov; 57(16):3464-3471. PubMed ID: 26853094
[TBL] [Abstract][Full Text] [Related]
14. Epidemiology of cardiovascular disease: recent novel outlooks on risk factors and clinical approaches.
Niiranen TJ; Vasan RS
Expert Rev Cardiovasc Ther; 2016 Jul; 14(7):855-69. PubMed ID: 27057779
[TBL] [Abstract][Full Text] [Related]
15. Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine.
Ogino S; Nishihara R; VanderWeele TJ; Wang M; Nishi A; Lochhead P; Qian ZR; Zhang X; Wu K; Nan H; Yoshida K; Milner DA; Chan AT; Field AE; Camargo CA; Williams MA; Giovannucci EL
Epidemiology; 2016 Jul; 27(4):602-11. PubMed ID: 26928707
[TBL] [Abstract][Full Text] [Related]
16. C/VDdb: A multi-omics expression profiling database for a knowledge-driven approach in cardiovascular disease (CVD).
Fernandes M; Patel A; Husi H
PLoS One; 2018; 13(11):e0207371. PubMed ID: 30419069
[TBL] [Abstract][Full Text] [Related]
17. Next generation microbiological risk assessment-Potential of omics data for hazard characterisation.
Haddad N; Johnson N; Kathariou S; Métris A; Phister T; Pielaat A; Tassou C; Wells-Bennik MHJ; Zwietering MH
Int J Food Microbiol; 2018 Dec; 287():28-39. PubMed ID: 29703417
[TBL] [Abstract][Full Text] [Related]
18. Spatial multi-omics: novel tools to study the complexity of cardiovascular diseases.
Kiessling P; Kuppe C
Genome Med; 2024 Jan; 16(1):14. PubMed ID: 38238823
[TBL] [Abstract][Full Text] [Related]
19. CHO-Omics Review: The Impact of Current and Emerging Technologies on Chinese Hamster Ovary Based Bioproduction.
Stolfa G; Smonskey MT; Boniface R; Hachmann AB; Gulde P; Joshi AD; Pierce AP; Jacobia SJ; Campbell A
Biotechnol J; 2018 Mar; 13(3):e1700227. PubMed ID: 29072373
[TBL] [Abstract][Full Text] [Related]
20. Omics phenotyping in heart failure: the next frontier.
Bayes-Genis A; Liu PP; Lanfear DE; de Boer RA; González A; Thum T; Emdin M; Januzzi JL
Eur Heart J; 2020 Sep; 41(36):3477-3484. PubMed ID: 32337540
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
